Arcutis Says Health Canada Accepts For Review Roflumilast Cream NDS For Plaque Psoriasis

RTTNews | 1125 dagar sedan
Arcutis Says Health Canada Accepts For Review Roflumilast Cream NDS For Plaque Psoriasis

(RTTNews) - Arcutis Biotherapeutics, Inc. (ARQT) announced Monday that Health Canada has accepted for review the New Drug Submission (NDS) for roflumilast cream 0.3% for the treatment of plaque psoriasis in adults and adolescents. The target action date is April 30, 2023.

Roflumilast cream (ARQ-151) is a once-daily topical formulation of roflumilast, a highly potent and selective inhibitor of phosphodiesterase type 4 (PDE4), an enzyme that drives overactive immune responses. PDE4 is an established target in dermatology.

Arcutis' NDS submission is supported by positive data from Arcutis' pivotal Phase 3 program and two long-term open label studies. DERMIS-1 and DERMIS-2 were identical Phase 3 randomized, parallel, double-blind, vehicle-controlled, multi-national, multi-center studies to evaluate the safety and efficacy of roflumilast cream 0.3%.

A new drug application (NDA) for roflumilast cream for the treatment of plaque psoriasis in adolescents and adults is also under review by the U.S. Food & Drug Administration (FDA). The FDA has set a target action date of July 29, 2022.

For More Such Health News, visit rttnews.com

read more
Arcutis Biotherapeutics Appoints David Topper To Succeed John Smither As CFO

Arcutis Biotherapeutics Appoints David Topper To Succeed John Smither As CFO

Medical dermatology company Arcutis Biotherapeutics, Inc. (ARQT) announced Wednesday that David Topper has been appointed Chief Financial Officer (CFO) effective April 10, 2024. Topper is replacing John Smither, who rejoined Arcutis as interim CFO in August 2023. Smither will remain at Arcutis through the end of April to ensure a smooth transition.
RTTNews | 486 dagar sedan
Swiss Market Ends Marginally Up

Swiss Market Ends Marginally Up

The Switzerland market ended marginally up on Friday despite exhibiting weakness for much of the time past noon. Investors continued to react to earnings and assess the economic impact of reciprocal tariffs, and stayed largely cautious with their moves. A report showing a drop in Swiss consumer confidence in the month of July hurt sentiment.
RTTNews | 18h 26minuter sedan
Major European Markets Close On Mixed Note

Major European Markets Close On Mixed Note

Major European markets turned in a mixed performance on Friday with investors largely staying cautious, assessing the impact of tariffs on global economic growth, and continuing to digest corporate earnings announcements and other data.
RTTNews | 18h 50minuter sedan
Positive Start Seen For Canadian Stocks

Positive Start Seen For Canadian Stocks

Canadian stocks may edge up a bit in early trades Friday morning with some encouraging earnings announcements and firm commodity prices aiding sentiment. Investors will also be reacting to the data showing a 41,000 jobs drop in Canadian employment in the month of July. Data from Statistics Canada also showed that the unemployment rate in Canada came in unchanged at 6.9%.
RTTNews | 23h 23minuter sedan
UK Market Roughly Flat; Mining Stocks Move Higher

UK Market Roughly Flat; Mining Stocks Move Higher

Amid a lack of economic and earnings data, U.K. stocks are moving in a tight range in somewhat lackluster trade on Friday. Investors are assessing the potential impact of the Trump administration's reciprocal tariffs on global economic growth. Optimism about a rate cut by the Fed next month is aiding sentiment a bit.
RTTNews | 1 dag sedan
CAC 40 Climbs Higher For 3rd Straight Day

CAC 40 Climbs Higher For 3rd Straight Day

French stocks are modestly higher on Friday, extending gains to a third straight session, with mostly encouraging corporate earnings announcements aiding sentiment. Concerns about the potential impact of Trump's reciprocal tariffs limit market's upside a bit.
RTTNews | 1 dag sedan